James Hendrix is an Executive Director for US Medical Affairs on the Alzheimer's Disease Medical Affairs team at Eli Lilly and Company. Prior to this role, they served as the Chief Scientific Officer for the LuMind IDSC Foundation and were the Director of Global Science Initiatives at the Alzheimer’s Association. With over 18 years of experience in the pharmaceutical industry, they have also held various leadership positions at Sanofi and Oligomerix, among others. James holds a BA in Chemistry from the University of Northern Colorado and a PhD in Chemistry from Colorado State University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices